Literature DB >> 11238065

Augmented senile plaque load in aged female beta-amyloid precursor protein-transgenic mice.

M J Callahan1, W J Lipinski, F Bian, R A Durham, A Pack, L C Walker.   

Abstract

Transgenic mice (Tg2576) overexpressing human beta-amyloid precursor protein with the Swedish mutation (APP695SWE) develop Alzheimer's disease-like amyloid beta protein (Abeta) deposits by 8 to 10 months of age. These mice show elevated levels of Abeta40 and Abeta42, as well as an age-related increase in diffuse and compact senile plaques in the brain. Senile plaque load was quantitated in the hippocampus and neocortex of 8- to 19-month-old male and female Tg2576 mice. In all mice, plaque burden increased markedly after the age of 12 months. At 15 and 19 months of age, senile plaque load was significantly greater in females than in males; in 91 mice studied at 15 months of age, the area occupied by plaques in female Tg2576 mice was nearly three times that of males. By enzyme-linked immunosorbent assay, female mice also had more Abeta40 and Abeta42 in the brain than did males, although this difference was less pronounced than the difference in histological plaque load. These data show that senescent female Tg2576 mice deposit more amyloid in the brain than do male mice, and may provide an animal model in which the influence of sex differences on cerebral amyloid pathology can be evaluated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238065      PMCID: PMC1850367          DOI: 10.1016/s0002-9440(10)64064-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  Understanding the role of estrogen on cognition and dementia.

Authors:  M Sano
Journal:  J Neural Transm Suppl       Date:  2000

2.  Increased plasma amyloid beta protein 1-42 levels in Down syndrome.

Authors:  P D Mehta; A J Dalton; S P Mehta; K S Kim; E A Sersen; H M Wisniewski
Journal:  Neurosci Lett       Date:  1998-01-23       Impact factor: 3.046

3.  Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.

Authors:  L A Holcomb; M N Gordon; P Jantzen; K Hsiao; K Duff; D Morgan
Journal:  Behav Genet       Date:  1999-05       Impact factor: 2.805

4.  Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study.

Authors:  P N Wang; S Q Liao; R S Liu; C Y Liu; H T Chao; S R Lu; H Y Yu; S J Wang; H C Liu
Journal:  Neurology       Date:  2000-06-13       Impact factor: 9.910

5.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

Authors:  M X Tang; D Jacobs; Y Stern; K Marder; P Schofield; B Gurland; H Andrews; R Mayeux
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

6.  Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm.

Authors:  L Fratiglioni; M Viitanen; E von Strauss; V Tontodonati; A Herlitz; B Winblad
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

7.  Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study.

Authors:  R A Mulnard; C W Cotman; C Kawas; C H van Dyck; M Sano; R Doody; E Koss; E Pfeiffer; S Jin; A Gamst; M Grundman; R Thomas; L J Thal
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

8.  An age-related correlation between levels of beta-amyloid precursor protein and beta-amyloid in human cerebrospinal fluid.

Authors:  R T Carroll; M R Lust; K S Kim; P D Doyle; M R Emmerling
Journal:  Biochem Biophys Res Commun       Date:  1995-05-16       Impact factor: 3.575

9.  Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.

Authors:  K Hsiao; P Chapman; S Nilsen; C Eckman; Y Harigaya; S Younkin; F Yang; G Cole
Journal:  Science       Date:  1996-10-04       Impact factor: 47.728

10.  Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women.

Authors:  D Applebaum-Bowden; P McLean; A Steinmetz; D Fontana; C Matthys; G R Warnick; M Cheung; J J Albers; W R Hazzard
Journal:  J Lipid Res       Date:  1989-12       Impact factor: 5.922

View more
  108 in total

Review 1.  Alzheimer's disease in man and transgenic mice: females at higher risk.

Authors:  R S Turner
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

2.  Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis.

Authors:  Kunihiro Uryu; Helmut Laurer; Tracy McIntosh; Domenico Praticò; Daniel Martinez; Susan Leight; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

Review 3.  Impact of estrogen therapy on Alzheimer's disease: a fork in the road?

Authors:  Roberta D Brinton
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

4.  Building a more perfect beast: APP transgenic mice with neuronal loss.

Authors:  Dennis W Dickson
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

5.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

6.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

7.  CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease.

Authors:  B P Imbimbo; B Hutter-Paier; G Villetti; F Facchinetti; V Cenacchi; R Volta; A Lanzillotta; M Pizzi; M Windisch
Journal:  Br J Pharmacol       Date:  2009-03       Impact factor: 8.739

Review 8.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

9.  Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.

Authors:  Jungsu Kim; Joseph M Castellano; Hong Jiang; Jacob M Basak; Maia Parsadanian; Vi Pham; Stephanie M Mason; Steven M Paul; David M Holtzman
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

10.  Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.

Authors:  S Schäfer; O Wirths; G Multhaup; T A Bayer
Journal:  J Neural Transm (Vienna)       Date:  2006-10-31       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.